As the secondary choice of artery grafts, radial artery is more and more used to achieve multiple arterial revascularization in CABG. Risk factors for predictors of major cardiovascular adverse events (MACE) after CABG using radial-artery grafts (RA-CABG), however, remain uncertain. This case-control study aims to identify the baseline predictors of MACE after RA-CABG. We will collect the baseline characteristics and perioperative data of patients underwent RA-CABG from Jan. 2009 to Dec. 2019 in our single center. By reviewing the latest follow-up records, we will examine the correlation between the baseline characteristics and clinical outcomes (MACEs), then identify the independent risk factors for predictors of MACEs after RA-CABG.
Study Type
OBSERVATIONAL
Enrollment
370
Ruijin Hospital Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China
7-day MACE-4
a composite of all-cause death, myocardial infraction, stroke and repeat revascularization
Time frame: 7 days post-CABG
30-day MACE-4
a composite of all-cause death, myocardial infraction, stroke and repeat revascularization
Time frame: 30 days post-CABG
1-year MACE-4
a composite of all-cause death, myocardial infraction, stroke and repeat revascularization
Time frame: 1 year post-CABG
3-year MACE-4
a composite of all-cause death, myocardial infraction, stroke and repeat revascularization
Time frame: 3 years post-CABG
MACE-3
a composite of CV-death, myocardial infraction and stroke
Time frame: 7 days, 30 days, 1 year, and 3 years post-CABG
All-cause death
Death from any cause
Time frame: 7 days, 30 days, 1 year, and 3 years post-CABG
CV-death
Including death resulting from an acute myocardial infarction , sudden cardiac death, death due to heart failure, death due to stroke, death due to cardiovascular procedures, death due to cardiovascular hemorrhage, and death due to other cardiovascular causes
Time frame: 7 days, 30 days, 1 year, and 3 years post-CABG
Myocardial infraction
According to the 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials, including CABG-related MI, non CABG-related MI, silent MI and unknown type.
Time frame: 7 days, 30 days, 1 year, and 3 years post-CABG
Stroke
According to the 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials, including ischemic, hemorrhagic and unknown type.
Time frame: 7 days, 30 days, 1 year, and 3 years post-CABG
Repeat revascularization
According to the 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials, including any PCI and CABG.
Time frame: 7 days, 30 days, 1 year, and 3 years post-CABG
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.